Kristina Mischler, PA-C | |
10 Plum St, New Brunswick, NJ 08901-2065 | |
(732) 235-6333 | |
Not Available |
Full Name | Kristina Mischler |
---|---|
Gender | Female |
Speciality | |
Experience | Years |
Location | 10 Plum St, New Brunswick, New Jersey |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1104395193 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
363A00000X | Physician Assistant | (* (Not Available)) | Secondary |
207T00000X | Neurological Surgery | 25MP00562900 (New Jersey) | Primary |
Mailing Address | Practice Location Address |
---|---|
Kristina Mischler, PA-C 66 W Gilbert St, Tinton Falls, NJ 07701-4947 Ph: (843) 459-4120 | Kristina Mischler, PA-C 10 Plum St, New Brunswick, NJ 08901-2065 Ph: (732) 235-6333 |
News Archive
A research team from the National University of Singapore (NUS) has identified a new avenue to maintain bone health while reducing bone resorption.
Zydus Cadila, a global healthcare provider and one of India's leading healthcare companies has received Phase I clinical trial permission from the DCGI for ZYOG1 - a novel GLP-1 agonist. Designed and developed at the Zydus Research Centre using a unique platform technology, ZYOG1 is a novel, oral, anti-diabetic molecule.
Diagnostics company Cepheid on Monday signed deals with PEPFAR, USAID, UNITAID, and the Bill & Melinda Gates Foundation to immediately reduce the price of its Xpert MTB/RIF test kit for its GeneXpert tuberculosis (TB) diagnostic system in 145 countries, Reuters reports.
A new study has found that patient deaths from pneumonia and acute myocardial infarction were significantly more likely in hospitals where nurses reported schedules with long work hours.
› Verified 8 days ago